Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-17 Sale | 2025-12-19 9:04 pm | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 26,831 | $23.09 | $619,528 | 20,173,427 (Direct) | View |
| 2025-12-16 Sale | 2025-12-18 7:54 pm | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 1,694,614 | $23.05 | $39,065,213 | 16,353,113 (Indirect) | View |
| 2025-12-16 Sale | 2025-12-18 7:52 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 1,694,614 | $23.05 | $39,065,213 | 16,353,113 (Indirect) | View |
| 2025-12-16 Sale | 2025-12-18 7:41 pm | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director | 1,694,614 | $23.05 | $39,065,213 | 16,353,113 (Indirect) | View |
| 2025-12-15 Sale | 2025-12-17 9:00 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 1,740,000 | $21.68 | $37,723,200 | 19,417,740 (Direct) | View |
| 2025-12-11 Sale | 2025-12-15 9:34 pm | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 3,103,745 | $21.89 | $67,942,352 | 124,071,047 (Indirect Direct) | View |
| 2025-12-12 Purchase | 2025-12-12 5:17 pm | Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner | 16,666,666 | $21 | $349,999,986 | 113,317,007 (Direct) | View |
| 2025-12-09 Sale | 2025-12-11 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $20.85 | $4,170,000 | 7,374,431 (Direct) | View |
| 2025-11-19 Sale | 2025-11-21 8:24 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 1,300,000 | $20.23 | $26,304,500 | 18,047,727 (Indirect) | View |
| 2025-11-19 Sale | 2025-11-21 8:22 pm | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 1,300,000 | $20.23 | $26,304,500 | 18,047,727 (Indirect) | View |
| 2025-11-19 Sale | 2025-11-21 8:15 pm | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization Director | 1,300,000 | $20.23 | $26,304,500 | 18,047,727 (Indirect) | View |
| 2025-11-13 Sale | 2025-11-17 5:52 pm | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 1,854,603 | $20.46 | $37,939,112 | 47,011,613 (Indirect Direct) | View |
| 2025-11-07 Sale | 2025-11-07 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $20.22 | $4,044,000 | 7,581,482 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 851,383 | $16.99 | $14,467,502 | 2,060,077 (Direct) | View |
| 2025-10-09 Sale | 2025-10-14 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 125,667 | $16.29 | $2,047,336 | 3,228,452 (Direct) | View |
| 2025-10-06 Sale | 2025-10-08 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 665,159 | $16.21 | $10,781,813 | 17,621,520 (Direct) | View |
| 2025-09-19 Sale | 2025-09-23 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 1,711,000 | $14.92 | $25,524,777 | 21,596,902 (Direct) | View |
| 2025-09-18 Purchase | 2025-09-18 7:28 pm | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 3,315 | $15.07 | $49,957 | 17,287,081 (Direct) | View |
| 2025-09-03 Sale | 2025-09-05 5:01 pm | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 1,775,749 | $12.65 | $22,456,210 | 48,866,216 (Indirect Direct) | View |
| 2025-08-20 Sale | 2025-08-22 9:00 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $11.72 | $1,172,000 | 9,692,482 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-20 Tax Withholding | 2025-12-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,129 | $22.41 | 386,144 (Direct) | View |
| 2025-12-17 Other | 2025-12-19 9:04 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 32,682 | $23.09 | 20,173,427 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-19 9:04 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 59,513 | $0 | 20,173,427 (Direct) | View |
| 2025-12-17 Exercise | 2025-12-19 9:04 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh President & CIO | 59,513 | $12.68 | 20,173,427 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 234,096 | $4.06 | 19,417,740 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 9:00 pm | N/A 2026-04-19 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 3,870,659 | $0 | 19,417,740 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 3,636,563 | $12.68 | 19,417,740 (Direct) | View |
| 2025-12-15 Other | 2025-12-17 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 2,130,659 | $21.68 | 19,417,740 (Direct) | View |
| 2025-12-15 Other | 2025-12-15 9:34 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 478,708 | $22.05 | 124,071,047 (Direct) | View |
| 2025-12-11 Exercise | 2025-12-15 9:34 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 7,374,868 | $0 | 124,071,047 (Direct) | View |
| 2025-12-11 Exercise | 2025-12-15 9:34 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 7,374,868 | $12.68 | 124,071,047 (Direct) | View |
| 2025-12-12 Other | 2025-12-15 9:34 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 2,696,866 | $21.96 | 124,071,047 (Direct) | View |
| 2025-12-11 Other | 2025-12-15 9:34 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 1,095,550 | $21.64 | 124,071,047 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $0 | 7,374,431 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 7,374,431 (Direct) | View |
| 2025-11-20 Tax Withholding | 2025-11-24 9:02 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,235 | $20.27 | 388,273 (Direct) | View |
| 2025-11-20 Tax Withholding | 2025-11-24 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 7,051 | $20.27 | 1,497,908 (Direct) | View |
| 2025-11-07 Exercise | 2025-11-07 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $20.22 | 7,581,482 (Direct) | View |
| 2025-11-07 Exercise | 2025-11-07 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 7,581,482 (Direct) | View |
| 2025-10-20 Option Award | 2025-10-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,056 | $0 | 56,904 (Direct) | View |
| 2025-10-20 Option Award | 2025-10-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 789 | $0 | 108,543 (Direct) | View |
| 2025-10-20 Tax Withholding | 2025-10-22 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 158 | $17.74 | 108,543 (Direct) | View |
| 2025-10-20 Option Award | 2025-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 1,507 | $0 | 118,388 (Direct) | View |
| 2025-10-20 Tax Withholding | 2025-10-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 281 | $17.74 | 118,388 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 851,383 | $0 | 2,060,077 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 851,383 | $15.85 | 2,060,077 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-14 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 125,667 | $0 | 3,228,452 (Direct) | View |
| 2025-10-09 Exercise | 2025-10-14 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 125,667 | $15.85 | 3,228,452 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 665,159 | $0 | 17,621,520 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 204,833 | $15.85 | 17,621,520 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 200,000 | $3.85 | 17,621,520 (Direct) | View |
| 2025-10-06 Exercise | 2025-10-08 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 260,326 | $7.45 | 17,621,520 (Direct) | View |
| 2025-09-28 Tax Withholding | 2025-09-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,341 | $15.17 | 389,508 (Direct) | View |
| 2025-09-20 Tax Withholding | 2025-09-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,129 | $15.04 | 391,849 (Direct) | View |
| 2025-09-19 Exercise | 2025-09-23 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 1,562,374 | $0 | 21,596,902 (Direct) | View |
| 2025-09-19 Exercise | 2025-09-23 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 1,562,374 | $3.85 | 21,596,902 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 48,250 | $0 | 1,982,129 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 48,250 | $0 | 9,004,890 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 5,270 | $13.77 | 9,004,890 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 48,250 | $0 | 77,626 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 937 | $13.77 | 77,626 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 48,250 | $0 | 152,931 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 2,043 | $13.77 | 152,931 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 48,250 | $0 | 144,920 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 3,282 | $13.77 | 144,920 (Direct) | View |
| 2025-09-10 Option Award | 2025-09-12 9:00 pm | N/A 2035-09-09 | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 48,250 | $0 | 91,235 (Direct) | View |
| 2025-09-10 Other | 2025-09-12 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,661 | $13.77 | 91,235 (Direct) | View |
| 2025-08-28 Tax Withholding | 2025-09-02 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,340 | $11.94 | 393,978 (Direct) | View |
| 2025-08-20 Tax Withholding | 2025-08-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,235 | $11.72 | 396,318 (Direct) | View |
| 2025-08-20 Exercise | 2025-08-22 9:00 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $0 | 9,692,482 (Direct) | View |
| 2025-08-20 Exercise | 2025-08-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 100,000 | $3.85 | 9,692,482 (Direct) | View |
| 2025-08-20 Tax Withholding | 2025-08-22 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 7,051 | $11.72 | 9,692,482 (Direct) | View |
| 2025-07-30 Option Award | 2025-08-01 9:12 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 13,736,547 | $0 | 13,736,547 (Direct) | View |
| 2025-07-30 Option Award | 2025-08-01 9:09 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & Immunovant CEO | 198,413 | $0 | 1,660,636 (Direct) | View |
| 2025-07-28 Tax Withholding | 2025-07-30 9:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 1,919 | $11.35 | 397,553 (Direct) | View |
Ownership | 2025-07-29 9:00 pm | N/A 2028-09-19 | Roivant Sciences Ltd. | ROIV | Torti Frank President and Vant Chair | 0 | $0 | 10,271,639 (Direct) | View |